How to win: NHS National Framework for Macitentan tablets

About this contract

Project title: NHS National Framework Agreement for Macitentan & Cladribine Tablets Offer reference number: CM/TNS/26/5748 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to a maximum of 24 months. CM/TNS/26/5748/01 Macitentan Lot 1 DCE/DLN: 1/10/2027 to 30/09/2029 (24 months) CELN Lot 2 DNW/DLS: 1/10/2027 to 31/01/2029 (16 months) NWLS Lot 3 DNE/DSW: 1/10/2027 to 30/09/2029 (24 months) NESW CM/TNS/26/5748/02 Cladribine Tablets Lot 1 DCE/DSW: 1/10/2027 to 30/09/2029 (24 months) CESW Lot 2 DLN/DNW: 1/10/2027 to 31/01/2029 (16 months) NWLN Lot 3 DLS/DNE: 1/10/2027 to 30/09/2028 (12 months) LSNE Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England

How to win contracts like this

• ✓Answer against the marking scheme, not the question text — NHS England scores each response, so map your evidence to the published criteria and weightings.
• ✓At £128,400,000, expect quality and social value to carry a large share of the score — price alone rarely wins goods work.
• ✓Show recent, comparable delivery: name similar goods contracts you've delivered for public bodies, with measurable outcomes.
• ✓Start early: it closes 17 November 2026 and a strong bid takes iteration.

BidWriter drafts your responses from your company profile, scores them against the marking scheme, and tracks your whole pipeline. Free to start — no card needed.

Related resources

Similar contracts